Experienced in Generalized Resistance to Thyroid Hormone

Carlo L. Acerini

Downing Place, 
Cambridge, ENG, GB 
Experienced in Generalized Resistance to Thyroid Hormone
Downing Place, 
Cambridge, ENG, GB 
OverviewLocationsClinical Research

Overview

Carlo Acerini practices in Cambridge, United Kingdom. Mr. Acerini is rated as an Experienced expert by MediFind in the treatment of Generalized Resistance to Thyroid Hormone. His top areas of expertise are Type 1 Diabetes (T1D), Intersex, Congenital Adrenal Hyperplasia (CAH), and Low Blood Sugar.

His clinical research consists of co-authoring 115 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Generalized Resistance to Thyroid Hormone.

Gender
Male

Locations

Downing Place, Cambridge, ENG CB23EB, United Kingdom
Other Locations
Glasgow, SCT G514TF, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase 3, Open-label, Randomized, Multicenter, 12 Months, Efficacy and Safety Study of Weekly MOD-4023 Compared to Daily Genotropin - Therapy in Pre-pubertal Children With Growth Hormone Deficiency
A Phase 3, Open-label, Randomized, Multicenter, 12 Months, Efficacy and Safety Study of Weekly MOD-4023 Compared to Daily Genotropin - Therapy in Pre-pubertal Children With Growth Hormone Deficiency
Enrollment Status: Completed
Publish Date: July 20, 2025
Intervention Type: Drug
Study Drugs: MOD-4023, Somatropin
Study Phase: Phase 3
Open-label, Multi-centre, Multi-national, Randomized 2-period Crossover Study Comparing Closed-loop Insulin Delivery With Sensor-augmented Pump Therapy Over 4 Months in Children 1-7 Years With Type 1 Diabetes at Home, With an Extension.
Open-label, Multi-centre, Multi-national, Randomized 2-period Crossover Study Comparing Closed-loop Insulin Delivery With Sensor-augmented Pump Therapy Over 4 Months in Children 1-7 Years With Type 1 Diabetes at Home, With an Extension.
Enrollment Status: Completed
Publish Date: March 27, 2025
Intervention Type: Other, Device
Study Phase: Not Applicable
An Open-label, Multicentre, Randomised, Single-period, Parallel Design Study to Assess the Effect of Closed Loop Insulin Delivery From Onset of Type 1 Diabetes in Youth on Residual Beta Cell Function Compared to Standard Insulin Therapy
An Open-label, Multicentre, Randomised, Single-period, Parallel Design Study to Assess the Effect of Closed Loop Insulin Delivery From Onset of Type 1 Diabetes in Youth on Residual Beta Cell Function Compared to Standard Insulin Therapy
Enrollment Status: Active_not_recruiting
Publish Date: May 16, 2024
Intervention Type: Device, Other
Study Phase: Not Applicable
A Multicenter, Open Label, Variable Dose, Two Arm Pilot Paediatric Phase 1 PK Study to Evaluate Testosterone Nasal Gel (4.5% w/w) in Hypogonadal Boys
A Multicenter, Open Label, Variable Dose, Two Arm Pilot Paediatric Phase 1 PK Study to Evaluate Testosterone Nasal Gel (4.5% w/w) in Hypogonadal Boys
Enrollment Status: Terminated
Publish Date: October 26, 2023
Intervention Type: Drug
Study Drug: Testosterone Nasal Gel [Natesto]
Study Phase: Phase 1
An Open-label, Multi-centre, Randomized, Single-period, Parallel Study to Assess the Efficacy, Safety and Utility of 6 Month Day-and-night Automated Closed-loop Insulin Delivery Under Free Living Conditions Compared to Insulin Pump Therapy in Children and Adolescents With Type 1 Diabetes
An Open-label, Multi-centre, Randomized, Single-period, Parallel Study to Assess the Efficacy, Safety and Utility of 6 Month Day-and-night Automated Closed-loop Insulin Delivery Under Free Living Conditions Compared to Insulin Pump Therapy in Children and Adolescents With Type 1 Diabetes
Enrollment Status: Completed
Publish Date: February 02, 2021
Intervention Type: Device
Study Phase: Not Applicable
An Innovative Approach Towards Understanding and Arresting Type 1 Diabetes (INNODIA)
An Innovative Approach Towards Understanding and Arresting Type 1 Diabetes (INNODIA)
Enrollment Status: Unknown
Publish Date: December 21, 2020
An Open-label, Multi-centre, Randomised, 2-period Cross-over Study to Assess the Efficacy and Safety of Closed Loop Insulin Delivery Using Diluted Insulin in Comparison With Closed Loop With Non-diluted Insulin Over 21 Days in Children With Type 1 Diabetes Aged 1 to 7 Years in the Home Setting
An Open-label, Multi-centre, Randomised, 2-period Cross-over Study to Assess the Efficacy and Safety of Closed Loop Insulin Delivery Using Diluted Insulin in Comparison With Closed Loop With Non-diluted Insulin Over 21 Days in Children With Type 1 Diabetes Aged 1 to 7 Years in the Home Setting
Enrollment Status: Completed
Publish Date: June 06, 2018
Intervention Type: Device
Study Phase: Not Applicable
An Open-label, Multi-centre, Randomised, Single-period, Parallel Design Study to Assess the Efficacy, Safety, Utility and Psychosocial Effect of 12 Week Day and Night Automated Closed Loop Glucose Control Combined With Pump Suspend Feature Compared to Sensor Augmented Insulin Pump Therapy in Youth and Adults With Type 1 Diabetes With Sub-optimal Glucose Control Under Free Living Conditions
An Open-label, Multi-centre, Randomised, Single-period, Parallel Design Study to Assess the Efficacy, Safety, Utility and Psychosocial Effect of 12 Week Day and Night Automated Closed Loop Glucose Control Combined With Pump Suspend Feature Compared to Sensor Augmented Insulin Pump Therapy in Youth and Adults With Type 1 Diabetes With Sub-optimal Glucose Control Under Free Living Conditions
Enrollment Status: Completed
Publish Date: March 13, 2018
Intervention Type: Device
Study Phase: Not Applicable
View 7 Less Clinical Trials

115 Total Publications

Androgens and child behavior: Color and toy preferences in children with congenital adrenal hyperplasia (CAH).
Androgens and child behavior: Color and toy preferences in children with congenital adrenal hyperplasia (CAH).
Journal: Hormones and behavior
Published: August 26, 2022

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Acerini's expertise for a condition
ConditionClose
    View All 21 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile